• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Living with cystic fibrosis

The only provincial organization "by and for" people living with cystic fibrosis, dedicated to their advocacy and support.

  • Home
  • The Cystic Fibrosis
    • Questions and answers
    • Medications
    • Protective measure – Coronavirus
  • Publications
    • Historical archives
    • Publications – Santé vous bien
  • Our NPO
    • Support us!
    • In remembrance of our heroes
    • Recognition Awards
    • Our partners
  • Services
    • Support
    • Forms
    • External Resources
  • News
  • Contact us
  • Become a member
  • Make a donation
  • Français

Search in our archives

Quebec announces newborn screening for Cystic Fibrosis

12 October 2018

Dr. Larry Lands, Director of Respiratory Medicine at the Montreal Children’s Hospital, is one of many people who welcomed the news that Quebec would be introducing newborn screening for cystic fibrosis (CF) on September 17. “Quebec is the last jurisdiction in North America to start newborn screening for CF,” says Dr. Lands. “It’s an important milestone and represents work done by many people for more than a decade.”

In 2016, the Journal of Cystic Fibrosis published a study led by Dr. Denise Mak of Cystic Fibrosis (CF) Canada and co-authored by Dr. Lands, which looked at data from the Canadian CF Registry on children in Alberta, Ontario and Quebec. The study analyzed factors such as growth, number of hospitalizations, and rates of infection from two bacteria often associated with CF. Children screened at birth who were then diagnosed with CF showed better outcomes across these measures than children who were diagnosed later without the benefit of newborn screening. “Despite access to top-notch therapy, the Quebec patients did not do as well on these measures of growth and development,” says Dr. Lands. “We concluded that newborn screening would lead to better long-term health outcomes.”

Identifying a key enzyme

All newborns in Quebec have a small blood test to check for certain diseases, and screening for CF will now be added to the testing. The CF test looks at the baby’s level of immune reactive trypsinogen (IRT), an enzyme produced by the pancreas. “If IRT is high, then the baby will be recommended for genetic testing,” says Dr. Lands. The genetic testing then determines if the child has the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Making new therapies available to more patients

Dr. Lands points out that it’s an exciting time in the management of cystic fibrosis because there are new therapies that correct the fundamental defect in the CFTR gene. Pharmaceutical companies which are making the first generation of correctors have already begun to conduct studies in children under two years old. “Our team members have been early adapters for these new correctors, and we’ve taken the approach of letting our families know what’s available and enrolling them in research trials,” says Dr. Lands.

The McGill University Health Centre (MUHC) is part of a national clinical trials network started by CF Canada, and Dr. Lands is heading up the MUHC site for the network. “This initiative will allow more patients to be involved in new therapies, and we’ll have the opportunity to bring in patients from across eastern Quebec,” he says. “There are a variety of pediatric studies going on now, and we’ll soon be starting a Phase I trial in adult CF patients.”

Source: https://www.thechildren.com/news-and-events/latest-news/quebec-announces-newborn-screening-cystic-fibrosisTienda outlet deportiva

Classified under: General

Reader Interactions

Leave a Reply

Your email address will not be published. Required fields are marked *

Footer

629, rue Prince-Arthur Ouest 
Montréal (Québec) H2X 1T9

514 288-3157 (Montréal area)
1 800 315-3157 (Toll free, everywhere in Canada)
info@vivreaveclafk.com

Search this website

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Sitemap

© 2022 · Vivre avec la fibrose kystique
Design · Geneviève Fournier Design